Technetium Tc-99m exametazime is a radiopharmaceutical diagnostic agent used as an adjunct for scintigraphy in the detection of altered regional cerebral perfusion in stroke. It can also be used for the labelling of leukocytes to localise intra-abdominal infections and inflammatory bowel disease.
- Primary indication
- Technetium Tc99m exametazime scintigraphy (with or without methylene blue stabilization) may be useful as an adjunct in the detection of altered regional cerebral perfusion in stroke.Curator reviewed · 3 structured indications
- First approval
- United States, 1988
- Also known as
- (99m)Tc HM-PAO · (99m)Tc HMPAO · [(99m)Tc] HM-PAO · Technetium (99mTc) exametazime · Technetium (99mTc) HMPAO
- Brand names
Resolves to
Clinical / RWD
What you can answer from here — as of October 29, 2024
Which other approved drugs treat the same conditions as Technetium Tc-99m exametazime, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account